BrainsWay Ltd. (BWAY) stock remained unchanged at $11.05 a share on NASDAQ. The stock opened at $11.05, fluctuating between $10.95 to $11.25 during the session.
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
Employees | 134 |
Beta | 0.37 |
Sales or Revenue | $31.79M |
5Y Sales Change% | 0.946% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |
BrainsWay Ltd. (NASDAQ: BWAY) stock price is $11.05 in the last trading session. During the trading session, BWAY stock reached the peak price of $11.25 while $10.95 was the lowest point it dropped to. The percentage change in BWAY stock occurred in the recent session was 0% while the dollar amount for the price change in BWAY stock was -.
The NASDAQ listed BWAY is part of Medical - Devices industry that operates in the broader Healthcare sector. BrainsWay Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Richard Scott Areglado
Senior Vice President & Chief Financial Officer
Mr. Menachem C. Klein Esq.
Vice President, Gen. Counsel & Corporation Sec.
Ms. Moria Ankri
Vice President R&D
Mr. Christopher J. Boyer Ph.D.
Vice President of Global Marketing
Mr. Avner Hagai
Founder & Director
Dr. Aron Tendler
Chief Medical Officer
Dr. Yiftach Roth Ph.D.
Founder & Chief Scientific Officer
Mr. Hadar Levy
Chief Executive Officer
Mr. Ido Marom
Chief Financial Officer
Prof. Abraham Zangen
Co-Founder, Member of Scientific Advisory Board & Director
Dr. Christopher R. von Jako Ph.D.
Pres & Chief Executive Officer
BWAY's closing price is 139.7% higher than its 52-week low of $4.61 where as its distance from 52-week high of $11.25 is -1.77%.
Number of BWAY employees currently stands at 134.
Official Website of BWAY is: https://www.brainsway.com
BWAY could be contacted at phone 972 258 24030 and can also be accessed through its website. BWAY operates from Bynet Building, Jerusalem, 9777518, Israel.
BWAY stock volume for the day was 75.08K shares. The average number of BWAY shares traded daily for last 3 months was 68.64K.
The market value of BWAY currently stands at $207.92M with its latest stock price at $11.05 and 18.82M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com